Snapshot from May 31, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Governments / AmfAR
NGO

AmfAR

Tracked across 2 events · 14 articles · First seen Jun 18, 2025 · Last active May 25, 2026

Sentiment
60
Attention
6
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
6 60
Tech
CAR-T Cell Therapy Suppresses HIV
Scientists, led by Steven Deeks of the University of California, San Francisco, are developing a CAR-T cell therapy to combat HIV. This therapy involves genetically engineering a patient's own T cells to find and kill…
Impact: AmfAR is funding some work to create easier-to-use versions of the CAR-T cell therapy.
May 12, 2026 · 7 articles
6 60
Tech
US Approves Gilead HIV Prevention Shot
Impact: Greg Millett, public policy director at AmfAR, commented on the potential of lenacapavir to end HIV transmission.
Jun 18, 2025 · 7 articles
Key Actions (1)
50 AmfAR funding workCAR-T Cell Therapy Suppresses HIV
NEWSDESK
Track AmfAR live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.